In Brief This Week: Sequenom; Almac Diagnostics; NHGRI, Coraid; CLC Bio, JCVI | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom said this week that University of Michigan researchers conducted a study that showed that the firm's MassArray technology can identify human papillomavirus infections in women who previously tested negative with the Qiagen Hybrid Capture 2 test.

According to the firm, its PCR-MS method detected the presence of high-risk HPV in 46.7 percent of women who had tested negative by Hybrid Capture 2. The study is scheduled to appear in the September 2009 edition of the Journal of Virological Methods.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.